hsCRP, decoded.

The editorial TLDR.

What hsCRP actually is.

C-reactive protein is made by the liver in response to inflammation anywhere in the body. When the immune system encounters injury, infection, or chronic irritation, signalling proteins called cytokines (especially IL-6) prompt the liver to manufacture more CRP. It travels in the bloodstream where, among other roles, it helps tag damaged cells and pathogens for immune clearance. CRP itself isn't the problem — it's the smoke that tells you the fire is on.

The "high-sensitivity" qualifier matters. Standard CRP tests are tuned to detect the high concentrations seen in major infection or autoimmune flares — measuring values that often land in the tens or hundreds of mg/L. They're useful for acute care but can't distinguish between a "low" result of 4 and a "low" result of 0.5, because both look essentially the same on the assay. Yet that difference, sustained over years, matters enormously for long-term cardiovascular outcomes. The hsCRP assay is calibrated to read accurately in that low band, which is why it became one of the standard markers in cardiovascular risk research starting in the 1990s.

"Inflammation is the smoke. hsCRP is the smoke detector turned up high enough to register the slow-burn version that takes a decade to do damage."

The link between chronic low-grade inflammation and cardiovascular disease is well established. The Reynolds Risk Score, used to estimate cardiovascular risk in women, explicitly incorporates hsCRP alongside cholesterol and blood pressure. The JUPITER trial demonstrated that statin therapy reduced cardiovascular events in people with elevated hsCRP and otherwise normal cholesterol — a finding that fundamentally shifted how preventive cardiologists think about risk. The CANTOS trial, with its anti-inflammatory IL-1β inhibitor, showed that reducing inflammation alone (without changing cholesterol) reduced cardiovascular events further.

Beyond cardiovascular medicine, hsCRP is increasingly used in metabolic medicine, women's-health practice, and oncology survivorship as a general read on the body's inflammatory tone. It isn't specific — it can't tell you where inflammation is coming from — but it's a useful index of how much there is.

Why hsCRP matters for women.

Several patterns make hsCRP particularly worth understanding for U.S. women.

Cardiovascular risk that hides on a standard panel. Roughly half of cardiovascular events in U.S. women occur in those with LDL-C considered "normal." Inflammation, captured by hsCRP, explains a meaningful share of that gap. The Reynolds Risk Score for women — developed specifically because the standard Framingham score underestimated women's cardiovascular risk — explicitly incorporates hsCRP. This is one of the more concrete examples of a biomarker that does a better job for women than the older, male-derived alternatives.

Autoimmune patterns. Women carry the bulk of the autoimmune disease burden in the United States — roughly 75% of all cases. Hashimoto's, lupus, rheumatoid arthritis, multiple sclerosis, and many other autoimmune conditions are far more common in women. hsCRP is not diagnostic for any of these, but a persistently elevated reading without an obvious cardiovascular or metabolic explanation can be one of the prompts for a broader autoimmune workup.

Polycystic ovary syndrome and metabolic syndrome. Women with PCOS, insulin resistance, fatty liver or metabolic syndrome typically run higher hsCRP than women without those patterns — sometimes meaningfully higher. The inflammation isn't separate from the metabolic picture; it's part of how insulin resistance translates into cardiovascular and reproductive consequences over time.

Perimenopause and menopause. The estrogen decline of perimenopause and menopause is associated with shifts in inflammatory markers as well as lipids. hsCRP often drifts upward through this window, particularly in women with central weight gain, sleep disruption, or already-elevated metabolic markers.

Pregnancy-related conditions. A history of preeclampsia, gestational diabetes or hypertension in pregnancy is increasingly recognised as a cardiovascular risk modifier. hsCRP can be one of the markers used in re-assessing risk five or ten years after these pregnancy patterns.

Postpartum. hsCRP rises during pregnancy and the early postpartum period; that's expected and not informative for long-term risk. Most clinicians wait at least three to six months postpartum before drawing it for screening purposes.

The everyday slow-burn. Even in women without a clear cardiovascular, autoimmune or metabolic story, chronically elevated hsCRP can sit underneath vague symptoms — fatigue, slow recovery, joint stiffness, mood flatness — and is occasionally the marker that prompts a useful look at sleep, stress, diet, alcohol use and movement patterns. None of these are diagnostic; all of them can be part of a thoughtful conversation about why the number is where it is.

What the ranges generally mean.

Most U.S. labs report hsCRP in milligrams per liter (mg/L). The educational bands published by the American Heart Association in 2003 — and still widely used clinically — are below.

Illustrative educational bands, not diagnostic thresholds. hsCRP varies with acute illness, recent infection, injury, intense exercise and pregnancy. Always discuss your specific result with a qualified healthcare provider.

What may drive hsCRP low or high.

The patterns below come up most often when hsCRP sits outside the comfortable zone — particularly in U.S. women.

What may drive hsCRP elevated.

• Recent infection or illness. Even a mild cold can push hsCRP into the intermediate or higher band for two to four weeks. Always worth contextualising before re-testing.
• Intense recent exercise or injury. Marathon training, a hard workout in the days before the draw, or a recent musculoskeletal injury can elevate hsCRP transiently.
• Insulin resistance, PCOS and metabolic syndrome. A consistent, well-documented driver in women. Often resolves with metabolic improvement.
• Visceral adiposity. Central abdominal fat is metabolically active and produces inflammatory cytokines. Among the cleaner predictors of chronic hsCRP elevation in midlife women.
• Sleep disruption. Chronic short sleep, sleep apnea and shift work are all associated with elevated hsCRP.
• Chronic stress. Sustained psychological stress is associated with modest hsCRP elevations in multiple studies.
• Diet patterns. Ultra-processed, high-sugar, high-refined-carbohydrate eating is associated with higher hsCRP. Mediterranean and similar patterns are associated with lower readings.
• Smoking and heavy alcohol use. Both elevate hsCRP independently.
• Autoimmune disease activity. Active rheumatoid arthritis, lupus, IBD and similar conditions can elevate hsCRP, sometimes meaningfully.
• Periodontal disease. Gum infection and inflammation are a well-documented source of low-grade systemic CRP elevation. Worth a dental check when other drivers are unclear.
• Estrogen-containing hormonal therapy. Oral estrogen (in some forms of HRT and combined oral contraception) can mildly elevate hsCRP through a liver effect. Transdermal estrogen typically does not.

What may drive hsCRP low.

• Generally healthy metabolic state. The most common reason for a persistently low reading is the absence of the drivers listed above.
• Anti-inflammatory diet and exercise patterns. Regular moderate exercise, Mediterranean-style eating, adequate sleep and stress management are all associated with lower readings.
• Statin and PCSK9 inhibitor therapy. These cholesterol-lowering medications reduce hsCRP independently of their lipid effects.
• Some immunomodulating treatments. Effective autoimmune treatment typically lowers hsCRP alongside other inflammatory markers.

Your provider will guide the conversation based on your full medical context. These prompts are designed to make sure hsCRP gets interpreted with the right context rather than as a number in isolation.

When to test, and how it's measured.

hsCRP is a standard venous blood draw. It's most informative when paired with a lipid panel — most modern cardiometabolic add-ons include both hsCRP and ApoB alongside the standard cholesterol values. No fasting is required for hsCRP itself, though a fasting draw is convenient if you're also doing triglycerides or insulin.

Timing matters. Because hsCRP rises with any acute inflammation, the timing rules are about avoiding artificially high readings. Many clinicians ask you to avoid testing within two to four weeks of any of the following: a cold or other infection, a dental procedure, surgery, a major injury, or an unusually intense workout. Pregnancy and the early postpartum window also elevate hsCRP for reasons unrelated to chronic risk. Most clinicians wait until at least 3–6 months postpartum before drawing for screening purposes.

Because of natural day-to-day variation, the AHA recommendation is to average two readings taken at least two weeks apart before using hsCRP for cardiovascular risk classification. A single elevated reading without context can be misleading; two consistent readings are far more informative.

Cycle day doesn't materially affect hsCRP. Hormonal contraception — particularly oral estrogen-containing forms — can elevate it modestly. Worth flagging on the requisition.

Direct-to-consumer at-home tests — Function Health, LetsGetChecked, Quest Direct and others — include hsCRP in most of their cardiovascular and cardiometabolic panels. They're useful for a baseline; they don't replace the conversation about what to do with the result. See our guide to at-home blood tests for women for a fuller comparison.

Related biomarkers worth understanding.

hsCRP rarely sits alone in a thoughtful workup. The markers below come up most often alongside it.

• ApoB — atherogenic particle count. The complementary cardiovascular marker to hsCRP in modern preventive cardiology.
• HbA1c — three-month average glucose. Often elevated alongside hsCRP in metabolic patterns.
• Fasting insulin and HOMA-IR — insulin resistance is one of the cleaner drivers of chronic hsCRP elevation.
• Lipoprotein(a) — Lp(a) — hereditary cardiovascular risk. Worth testing once in a lifetime, particularly with family history.
• TSH — thyroid. Subclinical hypothyroidism can mildly elevate hsCRP and is worth ruling out.
• Vitamin D — low vitamin D is associated with higher hsCRP in multiple studies. Worth checking alongside.